ResMed Inc (0KW4.L) Q3 2025 Earnings Report

In Q3 2025, ResMed Inc demonstrated strong financial performance, with revenues reaching $1.29 billion, marking a 7.92% year-over-year increase. The company recorded a net income of $365 million, contributing to an impressive 21.48% increase in net income on a year-over-year basis and a more modest 5.93% on a quarter-over-quarter basis. Management attributed this success to increased demand for respiratory care and cloud-based solutions, enhancing patient engagement and operational efficiencies. The earnings per share (EPS) saw a notable rise of 22.06% year-over-year, further reflecting the company's effective cost management and improved operational performance. These results highlight ResMed's robust market position and ability to capitalize on growth opportunities in the healthcare industry.